NASDAQ: POAIPredictive Oncology Inc Stock Ownership - Who owns Predictive Oncology?
Insider buying vs selling
Have Predictive Oncology Inc insiders been buying or selling?
No trades
There has been no insiders buying vs selling in the past 12 months.
Be the first to know when POAI insiders and whales buy or sell their stock.
POAI Shareholders
What type of owners hold Predictive Oncology Inc stock?
Institutional
Insider
Retail
| Name | Hold | Shares | Value | Type |
|---|---|---|---|---|
| Joshua Kornberg | 10,098.19% | 73,329,247 | $648.23M | Insider |
| Sok Partners LLC | 9,788.99% | 71,083,929 | $628.38M | Insider |
| Samuel Herschkowitz | 8,854.20% | 64,295,862 | $568.38M | Insider |
| Caron Partners LP | 659.09% | 4,786,082 | $42.31M | Insider |
| Chad A. Ruwe | 391.78% | 2,844,964 | $25.15M | Insider |
| Arnon I. Dreyfuss | 298.63% | 2,168,572 | $19.17M | Insider |
| Carl I. Schwartz | 235.72% | 1,711,742 | $15.13M | Insider |
| James E. Dauwalter | 142.61% | 1,035,572 | $9.15M | Insider |
| J. Melville Engle | 57.38% | 416,693 | $3.68M | Insider |
| Kevin R. Davidson | 45.43% | 329,927 | $2.92M | Insider |
POAI vs Medical Stocks
Predictive Oncology Stock Ownership FAQ
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletterWallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.